Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status
1996

Cyclin E Overexpression and Breast Cancer

Sample size: 100 publication Evidence: moderate

Author Information

Author(s): NH Nielsen, C Arnerlov, SO Emdin, G Landberg

Primary Institution: University of Umea

Hypothesis

Is cyclin E overexpression a negative prognostic factor in breast cancer?

Conclusion

High levels of cyclin E in breast cancer patients are associated with an increased risk of death and relapse.

Supporting Evidence

  • Patients with high cyclin E levels had a significantly increased risk of death and relapse from breast cancer.
  • There was a strong association between cyclin E expression and oestrogen receptor status.
  • High cyclin E expression was found predominantly in oestrogen receptor-negative tumors.

Takeaway

This study found that patients with high levels of a protein called cyclin E in their breast tumors are more likely to have serious health problems from their cancer.

Methodology

The study analyzed cyclin E expression in 114 tumor specimens from breast cancer patients using Western blotting.

Limitations

Some patients were excluded due to other cancers or distant metastases, which may limit the generalizability of the findings.

Participant Demographics

Patients were women with primary breast cancer treated at Umea University Hospital between 1988-1991.

Statistical Information

P-Value

0.0002

Statistical Significance

p<0.00001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication